Stocks and Investing Stocks and Investing
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018

M. Auster Maintained (BMRN) at Buy with Increased Target to $120 on, May 25th, 2018


Published on 2024-10-26 05:45:59 - WOPRAI, M. Auster
  Print publication without navigation


M. Auster of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $116 to $120 on, May 25th, 2018.

M. has made no other calls on BMRN in the last 4 months.



There are 6 other peers that have a rating on BMRN. Out of the 6 peers that are also analyzing BMRN, 0 agree with M.'s Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with M.


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Monday, April 30th, 2018
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $116 on, Friday, March 2nd, 2018
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $124 on, Friday, February 23rd, 2018
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $132 on, Friday, February 23rd, 2018
  • M. Ian Somaiya of "BMO Capital" Maintained at Buy with Increased Target to $125 on, Friday, February 23rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $102 on, Friday, February 23rd, 2018
Contributing Sources